Phoenix Horizon Europe

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the @worldkidneyday 2026 webinar: "Kidney health for all – caring for people, protecting the planet" 🗣️ @RaymondVanhold1 , @acssjr , Gloria Munoz, @FionaCLoud 👤 @LiLiHsiao1 , @dalatif 🗓️ March 4 🕓 2 pm CET 🔗 Free registration: lite.spr.ly/6005OaDN

🇪🇺@PHOENIX_nano has been selected as a featured success story in the @EU_Commission's #Science4EU campaign! Science4EU showcases how EU funding drives groundbreaking research and innovation that improves lives across Europe. 👉📰research-and-innovation.ec.europa.eu/events/special…

Read about the work and legacy of Professor Remuzzi, @MarioNegriIRCCS: phoenix-he.eu/2026/02/in-con…

We sat down with @MarioNegriIRCCS Director, Professor Dr Giuseppe Remuzzi, Editorial Board member of the @NEJM, member of Italy's prestigious Accademia dei Lincei, and a leader in transplant science. Read on👉 phoenix-he.eu/2026/02/in-con…

Come funziona il trapianto di organi e come si diventa donatori in Italia 🇮🇹 geopop.it/come-funziona-…

Our PHOENIX research team at @idibaps has published a major study uncovering how liver immune cells completely rewire their genetic programming. Dive into our accessible lay summary: phoenix-he.eu/2026/01/from-f… @CORDIS_EU @EU_HaDEA

The @PHOENIX_nano consortium met at the Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (@idibaps) in Barcelona for a one-day meeting on December 15th, 2025. Thanks to Professor Dr Pere Santamaria and his laboratory group members!

The european project @Phoenix_nano held its general assembly today at the IDIBAPS This project aims to revolutionise transplant medicine by developing a new immunotherapy that prevents graft rejection and induces transplant tolerance 👉f.mtr.cool/egnnqrrgma

@Phoenix_nano Project Coordinators @MarioNegriIRCCS's groundbreaking immunology research enables a transplant recipient to live without anti-rejection drugs. Featured in L'Eco di Bergamo, October 10, 2025 Read our summary in English: phoenix-he.eu/2025/10/extend…

@Phoenix_nano PI Prof Karim Boudjema @CHURennes appears in an episode of LEGEND, where he shares insights from his remarkable career as #livertransplant surgeon. In the interview, he reflects on the evolution of organ donation & memorable transplant cases phoenix-he.eu/2025/07/phoeni…

>300 early-career researchers met at the PhD Meeting (May 9–11) for 3 days of cutting-edge science & collaboration. 👏 Shout-out to Lucilla Turchetti (@MarioNegriIRCCS), who presented PHOENIX results on novel nanoparticle-based immunotherapy in kidney transplant models.

As we prepare for the #ESOTcongress 2025, we’re excited to highlight a transformative session in organ transplantation! 🌍 w/ @IptaPedsTx, this session will address key issues and surgical complexities, inspiring innovative solutions. 💡 👉 esot-apps.m-anage.com/esot2025/en-GB…

We are an Impact Success Story! hnn30.healthncp.net/pdf/success-st…

Today is #WorldHealthDay. This year's focus is on maternal and newborn health. Learn about the #EU4Health and #HorizonEU projects that contribute to securing healthy conditions for mothers and babies.

An organ transplant is a life-changing journey filled with hope, gratitude, and sometimes uncertainty. Lean on your loved ones, connect with others who have walked this path, and seek professional support when needed. #WorldKidneyDay #AreYourKidneysOK #KidneyHealthMatters

🚀 Reminder: Submit your abstract for #NME25 and showcase your research at Europe’s leading #nanomedicine event, happening in Barcelona, May 27–30, 2025. 📢 Selected hort talks & Poster Symposium! 👉 Deadline: February 28, 2025 Submit now: nme25.eu/abstract

6th Clinical Tolerance Workshop brought global experts together to discuss transplant tolerance, cell therapies, & autoimmunity. Key step toward #immunosuppression withdrawal & advancing patient care. #TXPforAll @stark_hl @fgissa #OpenAccess tinyurl.com/ym8nzjve

Ecoutez, partagez, le nouveau podcast de France Rein : vaccination et immunodepression que faire? francerein.org/actualites/his… avec les soutiens d'Astellas, Astra Zeneca, CSL vifor, B-Braun, et GSK